Adjunct Professor, Medicine, Tufts Medical Center

Gastroenterology

Dr. Peter A. Bonis, MD

Peter Bonis works in the field of Gastroenterology. He went to medical school at NYU School of Medicine. Doctor Peter A. Bonis, MD is a published doctor. He published 44 publications, including: 'Correlation of biochemical response to interferon alfa with histological improvement in hepatitis C: a meta-analysis of diagnostic test characteristics.'

Publications

Obliteration of symptomatic Schatzki rings with jumbo biopsy forceps (with video).
The epidemiology and characteristics of eosinophilic esophagitis.
Assessment of fractionated exhaled nitric oxide as a biomarker for the treatment of eosinophilic esophagitis.
Colchicine Plus Ursodiol Versus Methotrexate Plus Ursodiol in the Treatment of Primary Biliary Cirrhosis: Twenty-Year Follow-Up.
Eosinophilic esophagitis: Updated consensus recommendations for children and adults.
Long-term remission of nondysplastic Barrett's esophagus after multipolar electrocoagulation ablation: report of 139 patients with 10 years of follow-up.
Variation in prevalence, diagnostic criteria, and initial management options for eosinophilic gastrointestinal diseases in the United States.
Risk of non-melanoma skin cancer in autoimmune hepatitis.
Hereditary nonpolyposis colorectal cancer: diagnostic strategies and their implications.
Methotrexate for treatment of primary biliary cirrhosis.
Effects of fish oil supplementation on kidney transplantation: a systematic review and meta-analysis of randomized, controlled trials.
Short-term treatment with proton-pump inhibitors as a test for gastroesophageal reflux disease: a meta-analysis of diagnostic test characteristics.
Refractory scleritis in a patient with cryoglobulinemia and hepatitis C.
Predictors of clinical outcomes following fundoplication for gastroesophageal reflux disease remain insufficiently defined: a systematic review.
Triple therapy for patients with primary biliary cirrhosis with progressive disease despite ursodeoxycholic acid: another step forward.
Effects of omega-3 fatty acids on organ transplantation.
Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative re...
[Trial therapy with proton pump inhibitors is not a suitable test for gastroesophageal reflux disease; a meta-analysis of the diagnostic test characteristics].
The challenge of irritable bowel syndrome.
Correlation of biochemical response to interferon alfa with histological improvement in hepatitis C: a meta-analysis of diagnostic test characteristics.
A predictive model for the development of hepatocellular carcinoma, liver failure, or liver transplantation for patients presenting to clinic with chronic hepatitis C.
Methotrexate improves biochemical tests in patients with primary biliary cirrhosis who respond incompletely to ursodiol.
TT virus.
Clinical outcomes after hepatitis C infection from contaminated anti-D immune globulin.
Low-dose methotrexate in primary biliary cirrhosis.
Interferon and ribavirin for patients with chronic hepatitis C who did not respond to previous interferon therapy: a meta-analysis of controlled and uncontrolled trials.
Is liver fibrosis reversible?
Abscesses in Crohn's disease: outcome of medical versus surgical treatment.
Ringed esophagus: unclear relationship to gastroesophageal reflux disease.
Correlation of quality measures with estimates of treatment effect in meta-analyses of randomized controlled trials.
Short-term treatment of gastroesophageal reflux disease.
Quality incentive payment systems: promise and problems.
Reading and critically appraising systematic reviews and meta-analyses: a short primer with a focus on hepatology.
Modafinil for the treatment of fatigue in primary biliary cirrhosis.
Persistent cholestatic jaundice after ERCP.
Development and prospective validation of a model for predicting weaning in chronic ventilator dependent patients.
A randomized controlled trial of colchicine plus ursodiol versus methotrexate plus ursodiol in primary biliary cirrhosis: ten-year results.
Putting the puzzle together: epidemiological and clinical clues in the etiology of eosinophilic esophagitis.
Association of a clinical knowledge support system with improved patient safety, reduced complications and shorter length of stay among Medicare beneficiaries in acute...
Methotrexate in patients with primary biliary cirrhosis who respond incompletely to treatment with ursodeoxycholic acid.
Classification of villous atrophy with enhanced magnification endoscopy in patients with celiac disease and tropical sprue.
Summary of the First International Gastrointestinal Eosinophil Research Symposium.
Eosinophilic esophagitis in children and adults: a systematic review and consensus recommendations for diagnosis and treatment.

Schools

New York University
Tufts New England Med Center

Doctors Specialties

Gastroenterology

Accepted Insurances

Education

Tufts Medical Center
NYU School of Medicine

Helpful Reviews

Give Anonymous Review

Similar Doctors

	Dr. Kathleen E. Corey, MD This Doctor is OpenDoctor Recommended.
	Dr. Louis J. Cohen, MD
	Dr. Marwan Abou Gergi, MD This Doctor is OpenDoctor Recommended.
	Dr. Eric B. Cohen, MD This Doctor is OpenDoctor Recommended.
	Dr. Thomas C. Liu, MD This Doctor is OpenDoctor Recommended.
	Dr. Sagar Garud, MD This Doctor is OpenDoctor Recommended.
	Dr. Nitin Gupta, MD
	Dr. Tahereh Ghaziani, MD This Doctor is OpenDoctor Recommended.
	Dr. Bernard R. Aserkoff, MD This Doctor is OpenDoctor Recommended.
	Dr. Tyler M. Berzin, MD This Doctor is OpenDoctor Recommended.
	Dr. Hannah M. Lee, MD This Doctor is OpenDoctor Recommended.
	Dr. Harini Naidu, MD This Doctor is OpenDoctor Recommended.